Article Details

Biopharmaceutical Company Edgewise Therapeutics Closes $95 Million In Series C

Retrieved on: 2020-12-15 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Biopharmaceutical Company Edgewise Therapeutics Closes $95 Million In Series C. View article details on hiswai:

Excerpt

All of the company's existing investors OrbiMed, Novo Holdings, <b>US Venture</b> <b>Partners</b> (USVP), Deerfield Management, New Leaf Ventures, and ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up